Penumbra 3D Revascularization Device It is indicated for used in the revascularization of patien...

FDA Device Recall #Z-2702-2017 — Class I — June 9, 2017

Recall Summary

Recall Number Z-2702-2017
Classification Class I — Serious risk
Date Initiated June 9, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Penumbra Inc.
Location Alameda, CA
Product Type Devices
Quantity 155 units

Product Description

Penumbra 3D Revascularization Device It is indicated for used in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral-M1 and M2 segments) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment.

Reason for Recall

Penumbra has identified an issue in these four lots involving a raw material component of the delivery wire. This issue could result in breakage of the delivery wire, which could potentially lead to serious patient injury or death.

Distribution Pattern

Nationwide Distribution to the following states: AZ, CA, CO, FL, IN, MA, MI, MN, NV, NY, OH, OK, PA, SC, TN, TX, UT, VA, WV

Lot / Code Information

Lots C00644, C00645, C00646, C00717

Other Recalls from Penumbra Inc.

Recall # Classification Product Date
Z-0849-2021 Class I Penumbra JET 7 KIT Reperfusion Catheter+Penumbr... Dec 15, 2020
Z-0848-2021 Class I Penumbra JET 7 Reperfusion Catheter REF 5MAXJET... Dec 15, 2020
Z-0851-2021 Class I Penumbra JET 7MAX KIT Penumbra JET 7 Reperfusio... Dec 15, 2020
Z-0850-2021 Class I Penumbra JET 7 KIT Reperfusion Catheter+Penumbr... Dec 15, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.